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β-adrenoceptors (β-AR) stimulation increases cardiac function by rising
cAMP that activates protein kinase A (PKA) and enhances Ca2+-induced Ca2+-
release by phosphorylating proteins such as ryanodine receptors and phosphol-
amban, which are also targets of the Ca2+/Calmodulin Kinase II (CaMKII). Any
dysregulation of the β-AR pathway promotes arrhythmias. Local cAMP concen-
tration in heart is mainly regulated by phosphodiesterases (PDE) type 3 and 4.
Here, we investigated the proarrhythmic effects of PDE3 and PDE4 inhibition
and evaluated the relative contribution of PKA and CaMKII to these mecha-
nisms. An IonOptix system was used to record intracellular Ca2+ transients in
isolated adult rat and pig ventricular myocytes (ARVMs and APVMs) loaded
with 1μM Fura-2AM and paced at 1Hz. In ARVMs, PDE4 inhibition with
Ro20-1724 (Ro, 10μM) potentiated the inotropic effect of the β-AR agonist iso-
proterenol (Iso, 1nM) but induced spontaneous Ca2+ waves (SCWs) recorded
during 10s pacing pauses (2.3±0.2 SCWs/10s, n=15; p<0.001). Sarcoplasmic
reticulum (SR) Ca2+ load increased by 30±5% (n=13; p<0.001) in Iso, but dou-
bled (p<0.001) in Iso+Ro leading to SR Ca2+ leak (measured in a 0Na+,0Ca2+
solution±1mM tetracaine, n=7; p<0.001). PKA inhibition by H89 (10μM) sup-
pressed SCWs, SR Ca2+ leak and the inotropic effect of Iso±Ro. The CaMKII
inhibitor KN93 (10μM), unlike its inactive analogue KN92, reduced SR Ca2+
leak by 85% (n=16; p<0.001) and SCWs incidence by 72% (n=8; p<0.001)
without affecting the inotropic effect of Iso+Ro. KN93 blunted the SR Ca2+ leak
induced by PDE3 inhibition with cilostamide (Cil, 1μM, n=10; p<0.001) by
81% but preserved Ca2+ transients amplitude. Similarly, CaMKII inhibition pre-
vented SCWs evoked by Cil and Ro in APVMs.
These results show that PDE inhibitors exert inotropic effects via PKA but
lead to SCWs via both PKA and CaMKII activation. They also suggest the
potential use of CaMKII inhibitors as adjuncts to PDE inhibitors to limit their
proarrhythmic effects.
0392
AMPKα1 regulates cell adhesion and migration of human cardiac
fibroblasts via cytoskeletal remodelling pathway
Cécile Dufeys (1), Gauthier Noppe (1), Nicolas Marquet (1), Nicolas
Baeyens (2), Nicole Morel (2), Jean-Louis Vanoverschelde (1), Luc Ber-
trand (1), Christophe Beauloye (1), Sandrine Horman (1)
(1) Université Catholique de Louvain, Recherche Cardiovasculaire
CARD, Woluwe Saint-Lambert, Belgique – (2) Université Catholique de
Louvain, Physiologie cellulaire – FYCL, Woluwe St-Lambert, Belgique
Background: A key detrimental characteristic of left ventricular (LV)
remodelling is fibrosis. The pathogenesis of cardiac fibrosis includes migra-
tion of cardiac fibroblasts. Remodelling of actin cytoskeleton is a hallmark of
the migrating cells. AMP-activated protein kinase (AMPK) regulates actin
cytoskeleton organization and has been shown to influence LV remodelling.
In this study, we investigated whether A-769662, a pharmacological AMPK
activator, modulates human cardiac fibroblast (HCF) migration and adhesion
by affecting actin organization.
Methods: Single-cell migration was assessed by time-lapse imaging. Focal
adhesions (FA) were visualized by immunofluorescence together with fluores-
cent phalloidin to stain actin filaments. Phosphorylation state of myosin regu-
latory light chains (MLC) was determined by western blot analysis and
immunofluorescent staining. RhoA activity was assessed using a pull down
method.
Results: A-769662 significantly decreased HCF motility, in an AMPKα1-
dependent manner. In addition, A-769662-treated cells shifted from an elon-
gated shape, characterized by leading and trailing edges, to a more polygonal
one with numerous and thicker stress cables, mainly dorsal fibres and trans-
verse arcs. This was accompanied by markedly increased cell adhesion and
focal adhesion size. Concomitantly, AMPKα1 activation also resulted in a
sustained activation of RhoA that was associated with a significant increase in
MLC phosphorylation and its colocalization with transverse arcs.
Conclusion: We postulate that A-769662 counteracts HCF migration
through an AMPK-dependent sustained activation of the RhoA/MLC pathway,
promoting actin polymerization and contraction. Myosin II-generated tension
into FA is expected to promote their maturation and subsequently alter migra-
tion.
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Atrial natriuretic peptide antifibrotic properties are mainly described in
cardiac myocytes or in induced cardiac myofibroblasts (Angiotensin II or
TGF-β induced differentiation). In the present work, we investigate the
effects of ANP/NPRA/cGMP system in modulating rat cardiac fibroblasts
function. Cardiac fibroblasts were isolated from adult Wistar male rats and
cultured in the presence of serum in order to induce fibroblasts differentia-
tion. Cultures were then treated with ANP (1μM), 8-Br-cGMP (100μM) or
IBMX (100μM), a non-specific phosphodiesterases inhibitor. ANP signifi-
cantly decreased proliferation rate and collagen secretion. Its effect was
mimicked by the cGMP analog, while combining ANP with 8-BrcGMP did
not lead to additional effects. Moreover intracellular cGMP levels were ele-
vated when cells were incubated with ANP confirming that ANP intracel-
lular pathway is mediated by cGMP. Additionally, immunoblotting and
immunofluorescence were used to confirm the presence of guanylyl cyclase
specific natriuretic peptide receptors A and B. Finally we scanned specific
cGMP dependent PDEs via RT-qPCR, and noticed that inhibiting all PDEs
led to an important decrease in proliferation rate. Effect of ANP became
more prominent after 10 culture days, confirming the importance of ANP in
fibroblasts to myofibroblasts differentiation. Uncovering cellular aspects of
ANP/NPRA/cGMP signaling system provided more elements to help under-
stand cardiac fibrotic process.
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Mechanistic target of rapamycin (mTOR) is a central regulator of cell
growth, proliferation, survival and metabolism. mTOR inhibition is increa-
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